 <h1>Congratulations! 🎉 </h1>
    <p style="color:#637381;">All done! You’ve completed another milestone.</p>

To continue, enter your details to log in.

We’ve sent a 6‑digit code to #MAIL_ADDRESS#\nPlease check your inbox or spam folder and enter the code below to continue.

Verification code sent

Thank you for the payment. You can now access {collectionName} by simply clicking the button below.

Yes, you’ve successfully ordered! 🎉

Unlock This Exclusive Course

It seems that your email address is not currently on the authorized access list. Please ensure you are using the email address that was invited, or contact the content owner for assistance.

Verification Required for Access

Introduction to Biologics in Drug Discovery

Biologics are an important class of drugs

Examples of Important Biologics

Recombinant protein are growing class of drugs

Benefits and Limitations

Antibody Basics and Mechanisms

Recombinant Antibodies as drugs

The Structure of an Antibody

Immunoglobulin (Ig) Classes

Mechanisms of Action

Monoclonal and Humanized Antibodies

Monoclonal antibodies

Pros and cons of monoclonal antibodies

Need to Humanize Antibodies

Chimeric Antibodies

Humanized Antibodies

Antibody Development and Laboratory Methods

Antibody Development Timeline

Different ways to make antibodies

Phage display

Antibodies from transgenic mice

Pharmaceutical Applications and Case Studies

Pharmaceutical Antibodies

Top 20 Best-Selling Drugs of 2012

Antibodies in Autoimmune Disease

Quiz

Hypervariable Loops

A Dynamic Binding Site

Traditional mAb

Phage display of antibody fragments

Pros and cons of phage antibodies

Course Feedback

Learning objectives

Welcome to the 'Fundamentals of Drug Discovery and Therapeutic Antibody Development' course. In recent years, biologics have completely revolutionized the pharmaceutical industry, offering highly targeted and effective treatments for complex diseases that traditional small molecule drugs simply cannot address.

Welcome to the 'Fundamentals of Drug Discovery and Therapeutic Antibody Development' course. In recent years, biologics have completely revolutionized the pharmaceutical industry, offering highly targeted and effective treatments for complex diseases that traditional small molecule drugs simply cannot address. This comprehensive course is meticulously designed to take you through the fascinating world of biological therapies, focusing heavily on the development, engineering, and clinical application of therapeutic antibodies. You will start by exploring the foundational differences between biologics and small molecules, diving into the rapidly growing class of recombinant proteins and understanding their unique benefits and limitations. From there, we will unpack the intricate structure and mechanisms of antibodies, including the various immunoglobulin classes and exactly how they bind to and neutralize disease targets. The curriculum deeply explores the evolution of monoclonal antibodies, the critical need for humanization to prevent immune rejection, and the creation of chimeric and fully humanized antibodies. Furthermore, you will gain practical insights into the cutting-edge laboratory methods used in modern drug discovery, such as phage display technology and the use of transgenic mice. Finally, we will review real-world pharmaceutical applications, analyzing top-selling biological drugs and their profound impact on treating autoimmune diseases. Whether you are a biology student, a pharmaceutical professional, or a healthcare enthusiast, this course will equip you with a robust, industry-relevant understanding of how life-saving antibody therapies are discovered, developed, and successfully brought to market.

Fundamentals of Drug Discovery and Therapeutic Antibody Development

<div class="simple-box-wrapper">
    <div class="simple-box">
        <div class="column">
            <p>The landscape of modern medicine has been fundamentally transformed by the advent of biologics, representing a critical shift from traditional small-molecule drugs to complex, highly targeted therapies. This course provides a comprehensive exploration of this dynamic field, establishing a rigorous foundation in the principles of drug discovery with a specific focus on recombinant proteins and therapeutic antibodies. Learners will systematically examine the core differences between conventional pharmaceuticals and biological therapies, evaluating the unique clinical benefits, manufacturing challenges, and inherent limitations associated with these advanced treatments. By understanding the foundational role of biologics, participants will be prepared to analyze how these sophisticated molecules are engineered to address some of the most challenging medical conditions.</p>

<p>Progressing through the curriculum, the focus narrows to the intricate design, mechanisms of action, and production of therapeutic antibodies. The modules delve deeply into the structural components of immunoglobulins, the critical necessity of humanizing animal-derived antibodies to prevent adverse immune responses, and the sophisticated laboratory methodologies—such as phage display and the utilization of transgenic models—required to bring a biological drug from initial discovery to the clinical market. Furthermore, the course contextualizes these scientific principles through real-world pharmaceutical applications and historical case studies, highlighting the profound impact of monoclonal antibodies on autoimmune diseases and their significant economic footprint in the global pharmaceutical industry. Through detailed instructional content and structured assessments, this program equips learners with the essential knowledge to navigate the complex timeline and rigorous scientific demands of modern antibody drug development.</p>
        </div>
    </div>
</div>
